Thalidomide 4'-oxyacetamide-PEG1-amine |
| Catalog No.GC50626 |
Thalidomide 4'-oxyacétamide-PEG1-amine, un conjugué ligand-lieur E3 ligase synthétisé qui incorpore le ligand cereblon À base de thalidomide et un lieur, peut être utilisé dans la synthèse des PROTAC.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2204226-02-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cereblon ligand for PROTAC® research and development; incorporates a cereblon ligand plus a PEG linker with terminal amine ready for conjugation to a target protein ligand. Part of a range of functionalized tool molecules for PROTAC R&D. This product has been recently renamed. The previous name for this product was Thalidomide - linker 13 PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
0
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *